You are here

  • Home
  • Archive
  • Volume 64, Issue 6
  • Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature

Article Text

Article menu
Download PDFPDF
Extended report
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature
  1. K Warnatz1,
  2. A G Keskin1,
  3. M Uhl2,
  4. C Scholz1,
  5. A Katzenwadel3,
  6. P Vaith1,
  7. H H Peter1,
  8. U A Walker1
  1. 1Department of Rheumatology and Clinical Immunology, Albert-Ludwigs University, Freiburg, Germany
  2. 2Department of Radiology, Albert-Ludwigs University, Freiburg, Germany
  3. 3Department of Urology, Albert-Ludwigs University, Freiburg, Germany
  1. Correspondence to:
    Dr K Warnatz
    Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, Hugstetterstr 55, D-79106 Freiburg, Germany; warnatzmed1.ukl.uni-freiburg.de

Abstract

Background: Retroperitoneal fibrosis (RPF) and inflammatory aneurysm of the abdominal aorta (IAAA) are regarded as two manifestations of the same disease, termed “chronic periaortitis”.

Objective: To determine the optimal therapeutic and diagnostic approaches to IAAA.

Methods: The outcome of medical immunosuppressive and surgical treatment of 20 patients was examined. Measurements of the C reactive protein (CRP) were compared with contrast enhanced imaging studies in the follow up of the patients.

Results: The diameter of the periaortic mantle and its contrast enhancement improved in 13/15 (87%) patients given immunosuppressive treatment for a period of more than 6 months. Strong contrast enhancement was associated with a substantial rise in CRP, but no correlation between the CRP value and thickness of the fibrotic mass was found, even at intraindividual follow up.

Conclusions: Immunosuppressive treatment should be included in the first line treatment of patients with RPF and should be maintained long term. Imaging studies are better than CRP measurements in the evaluation of response to treatment.

  • AZA, azathioprine
  • CRP, C reactive protein
  • CT, computed tomography
  • CYC, cyclophosphamide
  • DJ, double J
  • IAAA, inflammatory aneurysm of the abdominal aorta
  • MMF, mycophenolate mofetil
  • MRI, magnetic resonance imaging
  • OCS, oral corticosteroids
  • RPF, retroperitoneal fibrosis
  • chronic periaortitis
  • Ormond’s disease
  • immunosuppression
  • aneurysms of the abdominal aorta
  • retroperitoneal fibrosis

https://doi.org/10.1136/ard.2004.029793

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes